Header Logo

Connection

RU CHEN to Pancreatic Neoplasms

Back to Details
This is a "connection" page, showing publications RU CHEN has written about Pancreatic Neoplasms.
RU CHEN
Connection Strength
3.766
Pancreatic Neoplasms
  1. Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer. Sci Rep. 2017 08 11; 7(1):7950.
    View in: PubMed
    Score: 0.335
  2. Glycoproteins and glycoproteomics in pancreatic cancer. World J Gastroenterol. 2016 Nov 14; 22(42):9288-9299.
    View in: PubMed
    Score: 0.319
  3. Proteomics analysis of bodily fluids in pancreatic cancer. Proteomics. 2015 Aug; 15(15):2705-15.
    View in: PubMed
    Score: 0.286
  4. Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma. Lab Invest. 2015 Jan; 95(1):43-55.
    View in: PubMed
    Score: 0.276
  5. Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges. Proteomics. 2013 Feb; 13(3-4):710-21.
    View in: PubMed
    Score: 0.244
  6. Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Cancer Biol Ther. 2012 Aug; 13(10):899-907.
    View in: PubMed
    Score: 0.237
  7. Pilot study of blood biomarker candidates for detection of pancreatic cancer. Pancreas. 2010 Oct; 39(7):981-8.
    View in: PubMed
    Score: 0.209
  8. Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia. Mol Cancer. 2010 Jun 15; 9:149.
    View in: PubMed
    Score: 0.204
  9. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics. 2007 Aug; 6(8):1331-42.
    View in: PubMed
    Score: 0.165
  10. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas. 2007 Jan; 34(1):70-9.
    View in: PubMed
    Score: 0.161
  11. Quantitative proteomic profiling of pancreatic cancer juice. Proteomics. 2006 Jul; 6(13):3871-9.
    View in: PubMed
    Score: 0.155
  12. Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology. 2005 Oct; 129(4):1187-97.
    View in: PubMed
    Score: 0.147
  13. Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics. 2005 Apr; 4(4):523-33.
    View in: PubMed
    Score: 0.141
  14. Proteomic Investigation of Glyceraldehyde-Derived Intracellular AGEs and Their Potential Influence on Pancreatic Ductal Cells. Cells. 2021 04 24; 10(5).
    View in: PubMed
    Score: 0.108
  15. X-aptamers targeting Thy-1 membrane glycoprotein in pancreatic ductal adenocarcinoma. Biochimie. 2021 Feb; 181:25-33.
    View in: PubMed
    Score: 0.105
  16. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer. Proteomics Clin Appl. 2017 09; 11(9-10).
    View in: PubMed
    Score: 0.083
  17. Quantitative Proteomics Based on Optimized Data-Independent Acquisition in Plasma Analysis. J Proteome Res. 2017 02 03; 16(2):665-676.
    View in: PubMed
    Score: 0.080
  18. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions. Radiology. 2015 Dec; 277(3):644-61.
    View in: PubMed
    Score: 0.075
  19. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma. J Proteome Res. 2014 Mar 07; 13(3):1293-306.
    View in: PubMed
    Score: 0.066
  20. Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Gastroenterology. 2013 Oct; 145(4):885-894.e3.
    View in: PubMed
    Score: 0.063
  21. Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. J Proteome Res. 2012 Mar 02; 11(3):1937-48.
    View in: PubMed
    Score: 0.057
  22. Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion. PLoS One. 2012; 7(1):e30219.
    View in: PubMed
    Score: 0.057
  23. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res. 2011 May 06; 10(5):2359-76.
    View in: PubMed
    Score: 0.054
  24. Quantitative proteomics investigation of pancreatic intraepithelial neoplasia. Electrophoresis. 2009 Apr; 30(7):1132-44.
    View in: PubMed
    Score: 0.047
  25. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med. 2006 Dec; 3(12):e516.
    View in: PubMed
    Score: 0.040
  26. Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res. 1995 Oct 01; 55(19):4264-7.
    View in: PubMed
    Score: 0.018
  27. Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. J Med Genet. 1995 May; 32(5):330-5.
    View in: PubMed
    Score: 0.018
  28. Proteomics portrait of archival lesions of chronic pancreatitis. PLoS One. 2011; 6(11):e27574.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.